Most healthcare insurers do cover TMS therapy and we are in-network with many including Medicare. We have on our team experts in gaining approval for TMs therapy. They know how to navigate the insurance maze in an efficient and timely manner.

Let us help determine if TMS therapy is covered by your health insurer.

BrainsWay Deep TMS treatment has been proven safe and effective, and has no known systemic side effects, as seen with medications.. The most common side effect is temporary, mild pain or discomfort in the area of the treatment site, which occurs during the treatment session. This typically occurs only during the first week of TMS treatment. Other side effects may include muscle twitching and jaw pain.

ECT and Deep TMS are vastly different. While ECT induces seizures BrainsWay Deep TMS therapy is focused to stimulates brain regions using brief magnetic pulses at an amplitude similar to that used in MRI systems. ECT requires anesthesia and the treatment can result in severe side effects, including memory loss, while BrainsWay Deep TMS therapy does not involve anesthesia, has no effects on memory, and is generally well-tolerated.

Over 1 million TMS treatments have been delivered in the US with a high rate of success. In our center we see almost 3 out of 4 patients have significant improvement, with over 50% reaching remission. This success in a group of patients who are not responding with multiple medication trials is one reason why most healthcare insurers cover TMS therapy.

BrainsWay is also indicated by the FDA as an intended adjunct treatment for adult patients suffering from Obsessive Compulsive Disorder (OCD)/FDA De Novo.

BrainsWay has been cleared by the CE for a variety of brain disorders:

• Alzheimer's disease
• Autism
• Bipolar disorder
• Chronic pain
• Major depressive disorder
• Parkinson's disease
• Posttraumatic stress disorder (PTSD)
• Schizophrenia (negative symptoms)
• Smoking cessation
• Stroke
• Multiple Sclerosis
• OCD - Obsessive Compulsive Disorder

BrainsWay has also been cleared by the FDA for treatment resistant depression and is indicated by the FDA as an intended adjunct treatment for adult patients suffering from Obsessive Compulsive Disorder (OCD)/FDA De Novo.

BrainsWay is also indicated by the FDA as an intended adjunct treatment for adult patients suffering from Obsessive Compulsive Disorder (OCD)/FDA De Novo.

Typically, patients hear a tapping sound and feel a tapping sensation in the head area during BrainsWay Deep TMS therapy session. To diminish the sound, the patient is provided with earplugs.

Some patients experience temporary, mild pain or discomfort in the area of the treatment site, which occurs during the treatment session. This typically occurs only during the first week BrainsWay Deep TMS treatment. Other side effects may include muscle twitching and jaw pain.

For more information about BrainsWay Deep TMS therapy, please contact the Deep TMS Center at 1855-200-dTMS.

Who is eligible for Brainsway's TMS therapy?

In general, our TMS therapy should not be used for patients with metal implants in or around the head (except for standard amalgam dental fillings). Please consult the Deep TMS Center at 1855-200-dTMS to verify whether your patient is eligible for Brainsway* Deep TMS therapy.

BrainsWay Deep TMS therapy has been tested in over 60 clinical studies, for various clinical indications, in leading institutions worldwide. The FDA has cleared BrainsWay Deep TMS therapy for treatment resistant depression and it is currently available in the U.S., Europe, and South America.

BrainsWay is also indicated by the FDA as an intended adjunct treatment for adult patients suffering from Obsessive Compulsive Disorder (OCD)/FDA De Novo.